IN2014DN10683A - - Google Patents

Info

Publication number
IN2014DN10683A
IN2014DN10683A IN10683DEN2014A IN2014DN10683A IN 2014DN10683 A IN2014DN10683 A IN 2014DN10683A IN 10683DEN2014 A IN10683DEN2014 A IN 10683DEN2014A IN 2014DN10683 A IN2014DN10683 A IN 2014DN10683A
Authority
IN
India
Prior art keywords
dopyridine
benzylcarbami
prevention
methyl
compound
Prior art date
Application number
Other languages
English (en)
Inventor
Filya Zhebrovska
Grygorii Kostiuk
Mykhailo Vanat
Viktor Margitych
Original Assignee
Farmak Internat Holding Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmak Internat Holding Gmbh filed Critical Farmak Internat Holding Gmbh
Publication of IN2014DN10683A publication Critical patent/IN2014DN10683A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
IN10683DEN2014 2012-05-18 2013-05-16 IN2014DN10683A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP2012/059258 WO2013170901A1 (en) 2012-05-18 2012-05-18 N-methyl-4-benzylcarbamidopyridinium chloride and a process for its preparation
PCT/EP2013/060158 WO2013171307A1 (en) 2012-05-18 2013-05-16 N-methyl-4-benzylcarbamidopyridinium chloride and a process for its preparation

Publications (1)

Publication Number Publication Date
IN2014DN10683A true IN2014DN10683A (ko) 2015-08-28

Family

ID=48483057

Family Applications (1)

Application Number Title Priority Date Filing Date
IN10683DEN2014 IN2014DN10683A (ko) 2012-05-18 2013-05-16

Country Status (12)

Country Link
US (2) US9493416B2 (ko)
EP (1) EP2850063B1 (ko)
JP (1) JP2015517513A (ko)
KR (1) KR101777561B1 (ko)
BR (1) BR112014028576B1 (ko)
CA (1) CA2873977C (ko)
EA (1) EA025409B1 (ko)
ES (1) ES2573286T3 (ko)
IN (1) IN2014DN10683A (ko)
PL (1) PL2850063T3 (ko)
UA (1) UA110889C2 (ko)
WO (2) WO2013170901A1 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2689775C1 (ru) * 2018-11-02 2019-05-29 Открытое акционерное общество "Авексима" Способ промышленного производства N-метил-4-бензилкарбамидопиридиния йодида

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU58612A1 (ru) 1939-10-29 1939-11-30 П.С. Мордовин Устройство дл включени в одну станционную линию двухабонентских аппаратов
SU548612A1 (ru) 1975-07-18 1977-02-28 Казанский Химико-Технологический Институт Им.С.М.Кирова Способ получени 10-хлорфеноксарсина
US4115390A (en) * 1977-08-19 1978-09-19 Nardi John C Method for the preparation of 1-alkyl pyridinium chlorides
AU670783B2 (en) * 1992-06-04 1996-08-01 Micro Flo Company Mepiquat chloride
WO2011158058A1 (en) 2010-06-17 2011-12-22 Farmak International Holding Gmbh α-CRYSTALLINE FORM OF CARBABENZPYRIDE

Also Published As

Publication number Publication date
EA201492161A1 (ru) 2015-03-31
US9493416B2 (en) 2016-11-15
JP2015517513A (ja) 2015-06-22
KR20150013124A (ko) 2015-02-04
WO2013171307A1 (en) 2013-11-21
WO2013170901A1 (en) 2013-11-21
EP2850063B1 (en) 2016-04-13
BR112014028576A2 (pt) 2017-06-27
ES2573286T3 (es) 2016-06-07
UA110889C2 (uk) 2016-02-25
PL2850063T3 (pl) 2016-10-31
CN104321312A (zh) 2015-01-28
US20140357677A1 (en) 2014-12-04
KR101777561B1 (ko) 2017-09-12
US20170037011A1 (en) 2017-02-09
EP2850063A1 (en) 2015-03-25
BR112014028576B1 (pt) 2020-11-03
CA2873977A1 (en) 2013-11-21
CA2873977C (en) 2019-09-17
EA025409B1 (ru) 2016-12-30

Similar Documents

Publication Publication Date Title
PH12015500274B1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
GB201118656D0 (en) New compounds
MX349004B (es) Nuevos compuestos.
TN2015000278A1 (en) Autotaxin inhibitors
GB201209613D0 (en) New compounds
JO3357B1 (ar) مركبات إيميدازوبيروليدينون
PH12014501738A1 (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
PH12015500713B1 (en) Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases
MD4589B1 (ro) Compoziţie farmaceutică cu conţinut de sofosbuvir şi utilizarea acesteia în tratamentul hepatitei virale C
MX366899B (es) Nuevos compuestos.
MX355267B (es) Análogos de carba-nucleósido 2´-sustituidos para tratamiento antivírico.
IN2014MN00986A (ko)
MX2013012053A (es) Inhibidores de replicacion viral, su proceso de preparacion y sus usos terapeuticos.
ZA201308617B (en) Use of thiazolide compounds for the prevention and treatment of viral diseases, cancer and diseases caused by intracellular infections
MX2015007916A (es) Peri-carbinoles.
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
NZ707773A (en) Methods of treating liver diseases
MX2015003034A (es) Jeringa que contiene una composicion, en particular farmaceutica, que comprende inmunoglobulinas, su metodo de fabricacion y uso.
IN2014DN03010A (ko)
IN2013MU03118A (ko)
MX2015003503A (es) Derivados de macrolidos, su preparacion y su uso terapeutico.
PH12015502703A1 (en) Pharmaceutical compositions
IN2014DN10683A (ko)
IN2014DN07897A (ko)
MX2013002446A (es) Derivados de tetrahidropirrolopirazina sustituidos.